Data / Drug companies / Opmx LLC
Opmx LLC: 97 products in the FDA NDC directory, labeler code 69729
Opmx LLC (labeler code 69729) lists 97 products in the FDA National Drug Code Directory, covering 22 finished drugs by generic name. By type: 97 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on September 7, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 69729
- Products in commercial distribution
- 97
- Packages
- 121
- Finished drugs by generic name
- 22
- Prescription products
- 0
- Over the counter products
- 97
- Flagged as original packager
- 21 of 21 products that carry the flag
- Started marketing in the last 12 months
- 28
- Earliest marketing start
- February 10, 2016
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 92 | 94.8% |
| Generic drugs (ANDA) | 5 | 5.2% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 97 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Acetaminophen | 17 | 214 |
| Dextromethorphan hydrobromide and guaifenesin | 8 | 16 |
| Hydrocortisone | 7 | 171 |
| Acetaminophen, caffeine | 7 | 14 |
| Acetaminophen, aspirin, caffeine | 5 | 48 |
| Acetaminophen, chlorpheniramine maleate, phenylephrine hcl | 5 | 8 |
| Acetaminophen, caffeine, pyrilamine maleate | 4 | 26 |
| Acetaminophen, dextromethorphan hydrobromide | 3 | 20 |
| Dextromethorphan hbr, guaifenesin | 2 | 67 |
| Cetirizine hydrochloride | 2 | 119 |
| Pyrantel pamoate | 2 | 13 |
| Tolnaftate | 1 | 99 |
| Acetaminophen, caffeine and pyrilamine maleate | 1 | 5 |
| Ibuprofen | 1 | 190 |
| Bacitracin, neomycin, polymyxin b, pramoxine | 1 | 1 |
| Esomeprazole | 1 | 26 |
| Acetaminohpen, dextromethorphan hydrobromide | 1 | 1 |
| Docusate sodium and sennosides | 1 | 29 |
| Aspirin | 1 | 134 |
| Miconazole nitrate | 1 | 101 |
| Guaifenesin, dextromethorphan hbr | 1 | 26 |
| Naproxen sodium | 1 | 100 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Capsule, liquid filled | 20 | 20.6% |
| Tablet | 19 | 19.6% |
| Syrup | 18 | 18.6% |
| Suspension | 10 | 10.3% |
| Cream | 9 | 9.3% |
| Tablet, film coated | 8 | 8.2% |
| Tablet, coated | 6 | 6.2% |
| Tablet, chewable | 2 | 2.1% |
| Ointment | 2 | 2.1% |
| Capsule, delayed release | 1 | 1% |
| Capsule | 1 | 1% |
| Capsule, gelatin coated | 1 | 1% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Tabcin Extra Strength | 69729-836 | Capsule, liquid filled | Over the counter monograph drugs | September 7, 2026 |
| Desenfriol-ito plus | 69729-835 | Suspension | Over the counter monograph drugs | September 5, 2026 |
| Pentrexcilina | 69729-824 | Suspension | Over the counter monograph drugs | September 3, 2026 |
| Mejoralito | 69729-823 | Suspension | Over the counter monograph drugs | September 3, 2026 |
| Barmicil Plus | 69729-834 | Cream | Over the counter monograph drugs | July 27, 2026 |
| Cardiaspirin protect | 69729-104 | Tablet, coated | Over the counter monograph drugs | July 21, 2026 |
| Viro Flu PM Relief | 69729-833 | Capsule, liquid filled | Over the counter monograph drugs | July 14, 2026 |
| Barmicil Plus | 69729-830 | Cream | Over the counter monograph drugs | July 9, 2026 |
| Quadriderm NF | 69729-828 | Cream | Over the counter monograph drugs | July 9, 2026 |
| Diprospan | 69729-794 | Cream | Over the counter monograph drugs | July 9, 2026 |
| Agrifen | 69729-816 | Capsule, liquid filled | Over the counter monograph drugs | July 8, 2026 |
| Viro-Flu AM | 69729-831 | Capsule, liquid filled | Over the counter monograph drugs | June 25, 2026 |
| Desenfriol d | 69729-829 | Tablet | Over the counter monograph drugs | June 18, 2026 |
| Neo-Lubrina Children | 69729-827 | Syrup | Over the counter monograph drugs | June 17, 2026 |
| Mejoralito Children | 69729-825 | Syrup | Over the counter monograph drugs | June 16, 2026 |
| Desenfriol-ito plus | 69729-815 | Syrup | Over the counter monograph drugs | June 15, 2026 |
| Buscapina | 69729-818 | Tablet, coated | Over the counter monograph drugs | March 11, 2026 |
| Riopan | 69729-791 | Capsule, delayed release | Generic drugs (ANDA) | March 4, 2026 |
| Tabcin ACTIVE | 69729-809 | Capsule, liquid filled | Over the counter monograph drugs | January 30, 2026 |
| Dolodol | 69729-601 | Tablet | Over the counter monograph drugs | January 30, 2026 |
| Resfriol-ito Children | 69729-161 | Tablet, chewable | Over the counter monograph drugs | January 30, 2026 |
| Mejoralito Children CHILDREN | 69729-160 | Tablet, chewable | Over the counter monograph drugs | January 30, 2026 |
| Viro-Flu AM Relief | 69729-056 | Capsule, liquid filled | Over the counter monograph drugs | January 30, 2026 |
| Coldtac Severe Cold Max Relief | 69729-808 | Capsule, liquid filled | Over the counter monograph drugs | January 29, 2026 |
| Crocin MAX | 69729-801 | Capsule, gelatin coated | Over the counter monograph drugs | January 29, 2026 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.